S&P 500   5,088.80
DOW   39,131.53
QQQ   437.56
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.56
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.56
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
S&P 500   5,088.80
DOW   39,131.53
QQQ   437.56
4 stocks benefitting from NVIDIA's explosive growth
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Analysts boosted Snowflake stock, big firms are buying now
First it was Tyson stock, now this food company is set to rally
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
Is CRISPR Therapeutics the NVIDIA of gene editing?
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Blue Chips And Billionaires Quietly Investing In "The New Oil" (Ad)
6 reasons to buy Teva Pharmaceuticals stock sooner than later
3 Chinese stocks poised for rebound
NASDAQ:ICUI

ICU Medical (ICUI) Stock Price, News & Analysis

$103.59
+0.64 (+0.62%)
(As of 02/23/2024 06:55 PM ET)
Today's Range
$102.64
$104.31
50-Day Range
$86.88
$107.11
52-Week Range
$78.28
$212.43
Volume
209,700 shs
Average Volume
251,522 shs
Market Capitalization
$2.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$122.00

ICU Medical MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
17.8% Upside
$122.00 Price Target
Short Interest
Bearish
5.43% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.47
Upright™ Environmental Score
News Sentiment
0.27mentions of ICU Medical in the last 14 days
Based on 7 Articles This Week
Insider Trading
Selling Shares
$152,204 Sold Last Quarter
Proj. Earnings Growth
-36.17%
From $5.06 to $3.23 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

3.33 out of 5 stars

Medical Sector

318th out of 935 stocks

Surgical & Medical Instruments Industry

42nd out of 93 stocks


ICUI stock logo

About ICU Medical Stock (NASDAQ:ICUI)

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; and ClearGuard HD, that maintains hemodialysis catheters. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 brand; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform that connects smart pumps to hospital's electronic health records, asset tracking systems, and alarm notification platforms; professional services; critical care products, such as Cogent 2-in-1 and CardioFlo hemodynamic monitoring systems; TDQ and OptiQ cardiac output monitoring catheters; TriOx venous oximetry catheters; Transpac blood pressure transducers; and SafeSet closed blood sampling and conservation systems. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.

ICUI Stock Price History

ICUI Stock News Headlines

ICUI Mar 2024 95.000 put
Blue Chips And Billionaires Quietly Investing In "The New Oil"
They're as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more.
ICUI Mar 2024 150.000 call
ICU Medical (ICUI) Set to Announce Quarterly Earnings on Tuesday
ICUI Mar 2024 125.000 call
ICUI Mar 2024 75.000 put
Blue Chips And Billionaires Quietly Investing In "The New Oil"
They're as essential to the tech and AI revolutions as oil was to the industrial revolution. Known as rare earth elements or REEs, these relatively unheard of commodities are essential to semiconductor chips, renewable energy, electric vehicles, and more.
Short Interest in ICU Medical, Inc. (NASDAQ:ICUI) Increases By 6.8%
ICU Medical, Inc. (ICUI)
ICU Medical: Who Is Coming To The Rescue?
ICU Medical Announces Third Quarter 2023 Results
See More Headlines
Receive ICUI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ICU Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/03/2021
Today
2/26/2024
Next Earnings (Confirmed)
2/27/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Health Care Supplies
Current Symbol
NASDAQ:ICUI
CUSIP
44930G10
Employees
14,500
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$122.00
High Stock Price Target
$134.00
Low Stock Price Target
$110.00
Potential Upside/Downside
+17.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-74,290,000.00
Pretax Margin
-2.80%

Debt

Sales & Book Value

Annual Sales
$2.28 billion
Cash Flow
$16.47 per share
Book Value
$87.15 per share

Miscellaneous

Free Float
22,330,000
Market Cap
$2.50 billion
Optionable
Optionable
Beta
0.65

Social Links

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report














ICUI Stock Analysis - Frequently Asked Questions

Should I buy or sell ICU Medical stock right now?

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ICU Medical in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ICUI shares.
View ICUI analyst ratings
or view top-rated stocks.

What is ICU Medical's stock price target for 2024?

2 Wall Street research analysts have issued 12-month price targets for ICU Medical's shares. Their ICUI share price targets range from $110.00 to $134.00. On average, they expect the company's share price to reach $122.00 in the next twelve months. This suggests a possible upside of 17.8% from the stock's current price.
View analysts price targets for ICUI
or view top-rated stocks among Wall Street analysts.

How have ICUI shares performed in 2024?

ICU Medical's stock was trading at $99.74 at the beginning of the year. Since then, ICUI stock has increased by 3.9% and is now trading at $103.59.
View the best growth stocks for 2024 here
.

Are investors shorting ICU Medical?

ICU Medical saw a increase in short interest in January. As of January 31st, there was short interest totaling 1,100,000 shares, an increase of 6.8% from the January 15th total of 1,030,000 shares. Based on an average trading volume of 401,000 shares, the short-interest ratio is currently 2.7 days. Currently, 5.4% of the company's shares are sold short.
View ICU Medical's Short Interest
.

When is ICU Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our ICUI earnings forecast
.

How can I listen to ICU Medical's earnings call?

ICU Medical will be holding an earnings conference call on Tuesday, February 27th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

How were ICU Medical's earnings last quarter?

ICU Medical, Inc. (NASDAQ:ICUI) announced its earnings results on Wednesday, November, 3rd. The medical instruments supplier reported $2.07 EPS for the quarter, topping analysts' consensus estimates of $1.57 by $0.50. The medical instruments supplier had revenue of $336.06 million for the quarter, compared to analyst estimates of $314.20 million. ICU Medical had a positive trailing twelve-month return on equity of 6.53% and a negative net margin of 1.25%. During the same quarter in the prior year, the company posted $1.61 EPS.

What ETFs hold ICU Medical's stock?

ETFs with the largest weight of ICU Medical (NASDAQ:ICUI) stock in their portfolio include SPDR S&P Health Care Equipment ETF (XHE).Principal Healthcare Innovators ETF (BTEC).

What is Vivek Jain's approval rating as ICU Medical's CEO?

81 employees have rated ICU Medical Chief Executive Officer Vivek Jain on Glassdoor.com. Vivek Jain has an approval rating of 73% among the company's employees.

What other stocks do shareholders of ICU Medical own?
Who are ICU Medical's major shareholders?

ICU Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.11%), Schroder Investment Management Group (1.80%), Point72 Asset Management L.P. (1.53%), Boston Trust Walden Corp (1.10%), WCM Investment Management LLC (1.01%) and Dimensional Fund Advisors LP (0.91%). Insiders that own company stock include Christian B Voigtlander, Daniel Woolson, Elisha W Finney, George A Lopez, Robert S Swinney, Virginia Ruth Sanzone and Vivek Jain.
View institutional ownership trends
.

How do I buy shares of ICU Medical?

Shares of ICUI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:ICUI) was last updated on 2/26/2024 by MarketBeat.com Staff